Precigen (PGEN) News Today $4.08 +0.14 (+3.55%) Closing price 10/21/2025 04:00 PM EasternExtended Trading$4.16 +0.08 (+2.06%) As of 09:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PGEN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Precigen (NASDAQ:PGEN) Trading 5.7% Higher - Time to Buy?October 21 at 1:49 PM | marketbeat.comA Look at Precigen (PGEN) Valuation Following FDA Approval of PAPZIMEOS for Recurrent Respiratory PapillomatosisOctober 17, 2025 | finance.yahoo.comPatient Opportunity Equity Strategy Q3 2025 Portfolio RecapOctober 16, 2025 | seekingalpha.comPrecigen (NASDAQ:PGEN) Trading Up 9.9% - Here's What HappenedOctober 16, 2025 | marketbeat.comPrecigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for ...October 13, 2025 | finance.yahoo.comPrecigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory PapillomatosisOctober 13, 2025 | prnewswire.comPrecigen, Inc. (NASDAQ:PGEN) Receives $8.25 Average Target Price from AnalystsOctober 13, 2025 | americanbankingnews.comWeiss Ratings Reaffirms Sell (D-) Rating for Precigen (NASDAQ:PGEN)October 10, 2025 | marketbeat.comPrecigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Moderate Buy" from BrokeragesOctober 8, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Trading 5.6% Higher - Still a Buy?October 7, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Director Jeffrey Kindler Sells 67,523 SharesOctober 2, 2025 | insidertrades.comPrecigen (NASDAQ:PGEN) Director Sells $243,082.80 in StockOctober 1, 2025 | marketbeat.comJeffrey Kindler Sells 106,837 Shares of Precigen (NASDAQ:PGEN) StockOctober 1, 2025 | marketbeat.comRandal Kirk Sells 1,809,667 Shares of Precigen (NASDAQ:PGEN) StockOctober 1, 2025 | insidertrades.comPrecigen (NASDAQ:PGEN) Director Randal Kirk Sells 1,809,667 SharesSeptember 30, 2025 | marketbeat.comCantor Fitzgerald Forecasts Weaker Earnings for PrecigenSeptember 29, 2025 | marketbeat.comInsider Buying: Precigen (NASDAQ:PGEN) CFO Acquires 2,932 Shares of StockSeptember 27, 2025 | insidertrades.comPrecigen (NASDAQ:PGEN) CFO Harry Jr. Thomasian Buys 2,932 SharesSeptember 26, 2025 | marketbeat.comHarry Jr. Thomasian Acquires 8,284 Shares of Precigen (NASDAQ:PGEN) StockSeptember 26, 2025 | marketbeat.comGoldman Sachs Group Inc. Has $497,000 Holdings in Precigen, Inc. $PGENSeptember 26, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Trading Down 6.1% - Time to Sell?September 25, 2025 | marketbeat.comThe Outlook For PrecigenSeptember 23, 2025 | seekingalpha.comPrecigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS CommercializationSeptember 23, 2025 | insidermonkey.comRandal Kirk Sells 1,403,360 Shares of Precigen (NASDAQ:PGEN) StockSeptember 20, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Director Randal Kirk Sells 3,596,892 SharesSeptember 20, 2025 | marketbeat.comRandal Kirk Sells 1,403,360 Shares of Precigen (NASDAQ:PGEN) StockSeptember 20, 2025 | insidertrades.comPrecigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS CommercializationSeptember 20, 2025 | msn.comPrecigen Converts Preferred Stock to Common SharesSeptember 17, 2025 | tipranks.comPrecigen (NASDAQ:PGEN) Trading 5.2% Higher - Here's WhySeptember 17, 2025 | marketbeat.com235,112 Shares in Precigen, Inc. $PGEN Acquired by Inspire Investing LLCSeptember 16, 2025 | marketbeat.comPrecigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOSSeptember 15, 2025 | finance.yahoo.comPrecigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesSeptember 15, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Trading Down 3.7% - Should You Sell?September 14, 2025 | marketbeat.comMetLife Investment Management LLC Invests $124,000 in Precigen, Inc. $PGENSeptember 11, 2025 | marketbeat.comParkman Healthcare Partners LLC Makes New $4.76 Million Investment in Precigen, Inc. $PGENSeptember 8, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Grows Stock Position in Precigen, Inc. $PGENSeptember 8, 2025 | marketbeat.com184,868 Shares in Precigen, Inc. $PGEN Purchased by Nuveen LLCSeptember 8, 2025 | marketbeat.comThese 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street AnalystsSeptember 7, 2025 | fool.comPrecigen (NASDAQ:PGEN) Director Acquires $69,000.00 in StockSeptember 6, 2025 | insidertrades.comPrecigen (NASDAQ:PGEN) Sets New 1-Year High - Here's What HappenedSeptember 5, 2025 | marketbeat.comPrecigen (NASDAQ:PGEN) Trading Up 7.8% - Here's What HappenedSeptember 4, 2025 | marketbeat.comPrecigen Secures $125M Loan for PAPZIMEOS ExpansionSeptember 3, 2025 | tipranks.comPrecigen Announces Up to $125 Million Non-Dilutive FinancingSeptember 3, 2025 | prnewswire.comPrecigen, Inc. - Special CallSeptember 2, 2025 | seekingalpha.comPrecigen, Inc. (PGEN) H.C. Wainwright Virtual Fireside Chat TranscriptSeptember 2, 2025 | seekingalpha.comCharles Schwab Investment Management Inc. Sells 62,098 Shares of Precigen, Inc. $PGENSeptember 2, 2025 | marketbeat.comCantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN)September 2, 2025 | finance.yahoo.comNancy Agee Buys 15,360 Shares of Precigen (NASDAQ:PGEN) StockAugust 30, 2025 | insidertrades.comPrecigen (NASDAQ:PGEN) Hits New 12-Month High - Here's WhyAugust 29, 2025 | marketbeat.comPrecigen (PGEN) Is Up 32.3% After FDA Approval of First Therapy for Recurrent Respiratory PapillomatosisAugust 27, 2025 | finance.yahoo.com Get Precigen News Delivered to You Automatically Sign up to receive the latest news and ratings for PGEN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos PGEN Media Mentions By Week PGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PGEN News Sentiment▼0.450.50▲Average Medical News Sentiment PGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PGEN Articles This Week▼44▲PGEN Articles Average Week Get the Latest News and Ratings for PGEN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Precigen and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies MENS News Today KYMR News Today AKRO News Today NAMS News Today CRNX News Today LNTH News Today VKTX News Today PRAX News Today MIRM News Today TLX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PGEN) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
